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Letter to the Editor
Are follicular large centrocytic and large centroblastic
lymphomas one entity?
Sir- In the Kiel-classification (Lennert, 1978, 1981)
malignant lymphomas derived from follicular center
cells (FCC) are subdivided into malignant
lymphoma (ML) centrocytic, ML centroblastic and
ML centroblastic/centrocytic. The former 2 types
generally reveal a diffuse growth pattern and the
latter a predominantly follicular growth. However,
some lymphomas composed mainly of centrocytes
or of centroblasts display a follicular growth. In the
recently proposed "working formulation (WF) for
clinical usage" (Rosenberg et al., 1982) follicular
lymphomas are subdivided into small cell, mixed
and large cell lymphomas; the former two groups
are classified among the low-grade and the latter
among the high-grade malignancies. Subdivision
according to the WF of a large group of
centroblastic/centrocytic lymphomas also revealed a
somewhat better survival in the small and mixed
cell groups than in the large cell group (Molenaar
et al., 1984). However, in view of earlier findings
(v.d. Berg et al., 1983) the impression was gained
that follicular large centrocytic lymphomas behave
less aggressively than their large centroblastic
counterparts. Therefore a group of 15 lymphomas
was selected from 439 FCC lymphomas diagnosed
at the lymph Node Registry in Kiel between 1953
and 1978 on the basis of (a) a (partly) follicular
growth pattern, (b) a predominance of large
centrocytes or of large centroblasts, (c) availability
of good quality paraffin sections (Giemsa and/or H
and E stained) and (d) information on survival. In
8 cases the tumours were composed predominantly
of large centrocytes (Group CC) and in 7 cases of
large centroblasts (group CB). In all cases some
small FCC were also found and the current groups
of cases seem to be at the borderline between ML
centroblastic/centrocytic and ML centrocytic or
centroblastic, respectively.
Similar to earlier observations (Molenaar et al.,
1983) patients in group CC tended to be younger
than those in group CB (Table I). No correlation
was found between the age at the time of diagnosis
and the length of the survival. Both the median and
5-years survival (Table I) and the survival curve
(Figure 1) suggest a more favourable course in
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Figure 1 Actuarial survival curves for the total group
of studied patients (all) and for the groups composed
predominantly of large centrocytes (CC, n=8) and of
large centroblasts (CB, n =7).
Table I Clinical and survival data
mean survival
n t MIF age all (mths) t (mths)' 5-yrs (%) follow-up'
All 15 10 10/5 58.6 33.3 18.5 40 89
CC 8 5 5/3 54.0 39.8 25.6 50 52
CB 7 5 5/2 63.8 26.0 11.4 0 89
amean survival times were calculated for all patients at risk and for those
that died during the study.
bmaximal follow-up (mths) ofpatients alive at the end of the study.
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Group CC than in Group CB, although not
statistically significant presumably due to the small
number of cases.
The current findings obtained in patients that
were mostly treated before the development of
modern therapeutic regimens corroborate with
earlier observations in recently treated patients (v.d.
Berg et al., 1983). In the latter study patients with
follicular lymphomas composed of small and large
centrocytes were found to require aggressive initial
treatment, but reached long complete remissions
afterwards. Patients with follicular lymphomas
composed of small and large centroblasts, on the
other hand, followed a relentless course from the
start. A better survival for large cleaved as
compared to large non-cleaved lymphomas has also
been reported by others (Stein et al., 1979; Aine et
al., 1982), but no mention was made in these
studies of a follicular growth. However, Barcos et
al. (1981) found a comparable survival in follicular
small and large cleaved and large non-cleaved
lymphomas. It may be concluded therefore, that the
evidence for a different behaviour of follicular large
centrocytic and large centroblastic lymphomas is as
yet inconclusive. Nevertheless, especially the
observed differences in response to therapy (v.d.
Berg et al., 1983), justify a critical approach to the
lumping together of all large cell follicular
lymphomas, since an initial complete response
seems to be the major determinant of long survival
(Cabanillas et al., 1979; Hermann et al., 1982).
Yours etc.,
W. M. Molenaar, J. Koudstaal
Dept. of Pathology, University of Groningen,
The Netherlands;
H. Bartels
Dept. of Internal Medicine, Medical
School of Liibeck, FRG.
We appreciate the cooperation of Prof. Dr K. Lennert,
the photographic help of Mr J. Scheffers and the
secretarial help of Mrs A. Boer.
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